BB BIOTECH AG - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Black Diamond Therapeutics, Inc. (BDTX)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: Black Diamond Therapeutics, Inc. Common Stock
Symbol: BDTX
Shares outstanding: 56.4M shares
Disclosed Ownership: 8.52M shares
Ownership: 15.1%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 02:36 PM
Date of event: Dec 31, 2024
Next filing: Mar 21, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	15.1%	8.52M	0	8.52M	/s/ Martin Gubler	Martin Gubler/Signatory Authority
Biotech Growth N.V.	15.1%	8.52M	0	8.52M	/s/ Jan Bootsma	Jan Bootsma/Signatory Authority